COLUMBUS and CLEVELAND, Ohio — BioOhio — Ohio’s bioscience industry developer — and the Global Cardiovascular Innovation Center (GCIC) housed at the Cleveland Clinic have published a bigger and better online directory of the state’s companies, organizations and research centers that are involved in the biosciences.
The Ohio Bioscience Resource Directory can be found at both BioOhio’s and the cardiovascular center’s Web sites.
“It’s really pretty remarkable,” said Tom Sudow, business development director for the cardiovascular center and vice president of attraction for Team NEO. “I was blown away as we worked on this project for about a year now. We found over 2,600 different locations that where part of the bioscience supply chain; 1,900 different companies out of that chain, all here in the state.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Listings in the directory include companies, value-chain suppliers, research organizations and business-to-business service providers. A mutual desire to catalog and promote Ohio’s bioscience industry value chain prompted BioOhio and the cardiovascular center to combine resources to expand and enhance the directory, which was first introduced in 2003.
In Ohio, “bioscience” is a broad and diverse field that includes biotechnology firms, drugs and therapeutics companies, medical device and equipment makers, research institutions, research and development facilities, medical laboratories, diagnostic imaging centers, clinical trial and regulatory consultants, as well as agricultural biotechnology interests.
Ohio has strengths in materials, parts, test and measurement, manufacturing, marketing resources and service organizations that can help the bioscience industry, according to BioOhio. The state is becoming a destination for bioscience business and research because of its world-class clinical and academic institutions, state innovation programs, available venture capital and skilled workforce.
“We believe Ohio will become a magnet for bioscience companies as they discover the breadth and depth of resources available here to serve them,” BioOhio director of business development Scott Osborne said in a written statement.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
“GCIC is pleased to sponsor the Ohio Bioscience Resource Directory,” said Mark Low, the center’s managing director, in the statement. “We have found that the extensive pool of skilled and talented value chain providers in Ohio, all within very close proximity and easy reach of companies located here, has been a tremendous advantage to the companies that we are incubating in the state.”
BioOhio will hold a webinar at 10 a.m. on Wednesday, Sept. 16, to demonstrate directory searches and queries, and answer questions. More information on the webinar can be found at https://www2.gotomeeting.com/register/736442699.
